Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Secarna Pharmaceuticals to announce positive new data at cancer research conference

April 1, 2025 Research and Development Oncology, Secarna Pharmaceuticals, oncology, research and development

Secarna Pharmaceuticals will present new preclinical data with its lead programme SECN-15 at the American Association for Cancer Research (AACR) …
News

Qfitlia approved by FDA to treat haemophilia A or B

March 31, 2025 Research and Development FDA, Haematology, Sanofi, haemophilia, pharma

The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran) as the first therapy in the US to treat …
News

Winners announced for 2025 PM Society Awards

March 31, 2025 Industry Associations, Research and Development Pharmacy, awards, pharma industry, pm society

The pharma marketing and healthcare communications industry gathered for the 39th PM Society Awards on 14 March 2025, which celebrates …
News

FDA grants fast track designation to chlamydia vaccine candidate

March 28, 2025 Research and Development FDA, Infections and infestations, Sanofi, chlamydia, vaccination

The US Food and Drug Association (FDA) has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention …
News
lungs

Pierre Fabre announces investments and partnerships in lung cancer research

March 27, 2025 Research and Development Oncology, Pierre Fabre Laboratories, lung cancer treatment, oncology

Pierre Fabre Laboratories has announced investment and partnership plans to improve the lives of lung cancer patients with unmet needs. …
News

Allegro shares promising preclinical results for osteoarthritis treatment

March 26, 2025 Clinical Trial Services, Research and Development Allegro, Orthopaedics, biomedical, clinical studies, osteoarthritis

Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is …
News

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID

March 26, 2025 Clinical Trial Services, Research and Development CVID, Immunology, Pharming Group, clinical trial, common variable immunodeficiency, immunodeficiency

Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in …
News

Recce Pharmaceuticals reports positive phase 2 data for skin infection drug

February 17, 2025 Research and Development Recce, Skin, diabetes, skin, skin infections

Recce Pharmaceuticals have announced positive patient data from its phase 2 clinical trial into RECCE 327 (R327), for the treatment …
News
1200px-european_flag_in_karlskrona_2011

European Commission launches new Biotech and Biomanufacturing Hub

February 3, 2025 Research and Development Biomanufacturing, Corporate, European Commission, Hub, european union

The European Commission has announced the opening of a new Biotech and Biomanufacturing Hub, supporting start-ups and small- to medium-sized …
News

Prenatal care could be revolutionised suggests studies from BrightHeart

January 31, 2025 Research and Development AI, BrightHeart, FDA, Obstetrics & Gynaecology, prenatal, studies

Private medical device and artificial intelligence (AI)-led company, BrightHeart, has revealed two studies which show an improvement to pre-natal care …
News

MHRA approve new treatment combo for transplant-ineligible multiple myeloma patients

January 30, 2025 Research and Development MHRA, Oncology, approvals, multiple myeloma, rare diseases

The Medicine and Healthcare products Regulatory Agency (MHRA) has approved quadruplet therapy, SARCLISA (isatuximab) in combination to treat multiple myeloma …
News

Positive topline results announced in phase 2 Alcohol Use Disorder study

January 29, 2025 Research and Development Beckley Psytech Ltd, King's College University, Poisoning and drug dependency, alcohol use disorder, clinical trials, positive results

Beckley Psytech Ltd, a clinical-stage biopharmaceutical company that specialises in the production of accessible medicines for mental health conditions, has …
News

Research collaboration announced between Oxford University and GSK

January 27, 2025 Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …
News

Combination first-in-line treatment approved for patients with non-small cell lung cancer

January 23, 2025 Research and Development J&J Innovative Medicine, Oncology, approval, non-small cell lung cancer

Johnson & Johnson Innovative Medicine  have announced that the European Commission (EC) has approved a marketing authorisation for the combination …
News

Biomarkers used in trial to prevent systematic onset of Crohns Disease before it begins in Europe-first project 

January 22, 2025 Research and Development Crohns Disease, Crohsn, Gastrointestinal tract, Takeda, biomarkers, ibd, project

Takeda, a global biopharmaceutical company, is due to launch a project, INTERCEPT, which will use biomarkers to prevent symptomatic onset …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025